Innovation City: Emerging with the Innovation Award was Akston Biosciences Corp., which proposes once-a-week insulin injections for diabetic cats and dogs.
Energesis and Akston Biosciences Sign Partnership Agreement for Companion Animal Obesity Drug Development
An antigen-specific immunotherapeutic, AKS-107, deletes insulin-specific B cells and prevents murine autoimmune diabetes
Immunogenicity phase II study evaluating booster capacity of nonadjuvanted AKS-452 SARS-Cov-2 RBD Fc vaccine
